Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

favicon.ico

favicon-16x16.png

favicon-32x32.png

apple-touch-icon.png

MoFo Favicons

Terms / Notices

Cookies

Privacy Policy

Attorney Advertising

Secure Login

Alumni

  Facebook

MoFo Facebook

  Linkedin

MoFo LinkedIN

Twitter

MoFo Twitter

YouTube

MoFo Youtube

Morrison Foerster - Footer

You have not solved the recaptcha challenge yet or session expired, try again.

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

Matthew I. Kreeger advises in the BioWorld article “Flaws in the IPR process give rise to some very inventive patent solutions” that Allergan’s decision to hand over key patents to the Saint Regis Mohawk Tribe “is a very aggressive strategy” that’s likely to have patent attorneys throughout the U.S. “hitting the books on tribal sovereign immunity.”

Flaws in the IPR process give rise to some very inventive patent solutions

About Morrison Forester

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

Matthew I. Kreeger advises in the BioWorld article “Flaws in the IPR process give rise to some very inventive patent solutions” that Allergan’s decision to hand over key patents to the Saint Regis Mohawk Tribe “is a very aggressive strategy” that’s likely to have patent attorneys throughout the U.S. “hitting the books on tribal sovereign immunity.”Mr. Kreeger also predicts the strategy won’t just be limited to life sciences, but rather a large number of industries that will welcome a way around the inter partes review process.Read the <a target="_blank" href="http://www.bioworld.com/content/flaws-ipr-process-give-rise-some-very-inventive-patent-solutions-0">full article</a>.

Flaws in the IPR process give rise to some very inventive patent solutions

Sign Up

Matthew I. Kreeger

Senior Counsel

Patent Litigation